Wave Life Sciences (WVE) Preferred Stock Liabilities (2015 - 2025)

Wave Life Sciences (WVE) has 11 years of Preferred Stock Liabilities data on file, last reported at $7.9 million in Q4 2025.

• Quarterly Preferred Stock Liabilities changed 0.0% year-over-year to $7.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.9 million (changed 0.0% YoY) and the FY2025 annual result came in at $7.9 million, changed 0.0% from the prior year.
• Preferred Stock Liabilities was little changed at $7.9 million in Q4 2025, from $7.9 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $7.9 million in Q1 2021 to a low of $7.9 million in Q1 2021.
• A 5-year average of $7.9 million and a median of $7.9 million in 2021 frame the typical range for Preferred Stock Liabilities.
• The widest YoY moves for Preferred Stock Liabilities: up 0.0% in 2021, down 0.0% in 2021.
• Tracing WVE's Preferred Stock Liabilities over 5 years: stood at $7.9 million in 2021, then changed by 0.0% to $7.9 million in 2022, then changed by 0.0% to $7.9 million in 2023, then changed by 0.0% to $7.9 million in 2024, then changed by 0.0% to $7.9 million in 2025.
• The last three Preferred Stock Liabilities figures came in at $7.9 million (Q4 2025), $7.9 million (Q3 2025), and $7.9 million (Q2 2025), per Business Quant data.